Table 1 Out of a total of 9951 patients presenting with cardiac CEDIS complaints, 82.1 and 81.9% of patients, respectively, had hsTnT and CK measured. Chest Pain (Cardiac Features) prompted biomarker testing most frequently. 1.2% of patients presenting to the ED were subsequently admitted with diagnoses of NSTE-ACS. hsTnT; high-sensitivity troponin T, CK; creatine kinase, NSTE-ACS; non-ST-elevation ACS

From: Routine creatine kinase testing does not provide clinical utility in the emergency department for diagnosis of acute coronary syndromes